AbbVie Inc. (ABBV) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1 NORTH WAUKEGAN ROAD NORTH CHICAGO, IL 60064 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 12,816 | 9,229 | 9,830 | 8,479 | 39,924 | 8,061 | |||
| Cash and cash equivalent | 12,814 | 9,201 | 9,746 | 8,449 | 39,924 | 7,289 | |||
| Short-term investments | 2 | 28 | 84 | 30 | 772 | ||||
| Receivables | 11,155 | 11,254 | 9,977 | 8,822 | 5,428 | 5,872 | |||
| Inventory, net of allowances, customer advances and progress billings | 4,099 | 3,579 | 3,128 | 3,310 | 1,813 | 1,605 | |||
| Inventory | 4,099 | 3,579 | 3,128 | 3,310 | 1,813 | 1,605 | |||
| Other undisclosed current assets | 4,932 | 4,401 | 4,993 | 3,562 | 2,354 | 1,407 | |||
| Total current assets: | 33,002 | 28,463 | 27,928 | 24,173 | 49,519 | 16,945 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 4,989 | 4,935 | 5,110 | 5,248 | 2,962 | 2,883 | |||
| Long-term investments and receivables | 304 | 241 | 277 | 293 | 93 | 1,420 | |||
| Long-term investments | 304 | 241 | 277 | 293 | 93 | 1,420 | |||
| Intangible assets, net (including goodwill) | 87,903 | 99,595 | 108,330 | 116,000 | 34,253 | 36,896 | |||
| Goodwill | 32,293 | 32,156 | 32,379 | 33,124 | 15,604 | 15,663 | |||
| Intangible assets, net (excluding goodwill) | 55,610 | 67,439 | 75,951 | 82,876 | 18,649 | 21,233 | |||
| Other noncurrent assets | 8,513 | 5,571 | 4,884 | 4,851 | 2,288 | 1,208 | |||
| Total noncurrent assets: | 101,709 | 110,342 | 118,601 | 126,392 | 39,596 | 42,407 | |||
| TOTAL ASSETS: | 134,711 | 138,805 | 146,529 | 150,565 | 89,115 | 59,352 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 30,650 | 25,402 | 22,699 | 20,159 | 11,832 | 11,931 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 2,543 | 2,335 | 1,771 | 1,607 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | 1,785 | 1,669 | 830 | 787 | ||
| Accounts payable | 3,688 | 2,934 | 2,882 | 2,276 | 1,452 | 1,546 | |||
| Accrued liabilities | 11,383 | 10,282 | 7,235 | 6,691 | 3,295 | 4,052 | |||
| Other undisclosed accounts payable and accrued liabilities | 15,579 | 12,186 | 8,254 | 7,188 | 4,484 | 3,939 | |||
| Debt | 7,191 | 4,136 | 12,495 | 8,502 | 3,753 | 5,308 | |||
| Total current liabilities: | 37,841 | 29,538 | 35,194 | 28,661 | 15,585 | 17,239 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 52,194 | 59,135 | 64,189 | 77,554 | 62,975 | 35,002 | |||
| Finance lease, liability | 27 | 17 | 25 | ✕ | |||||
| Other undisclosed long-term debt and lease obligation | 52,167 | 59,118 | 63,451 | 77,554 | 62,975 | 35,002 | |||
| Liabilities, other than long-term debt, including: | 34,279 | 32,845 | 31,710 | 31,253 | 17,597 | 14,490 | |||
| Accounts payable and accrued liabilities | 3,453 | 4,311 | |||||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 1,067 | ||
| Deferred income tax liabilities | 1,952 | 2,190 | 3,009 | 3,646 | ✕ | ||||
| Liability, pension and other postretirement and postemployment benefits | 2,949 | 1,840 | |||||||
| Other liabilities | 32,327 | 30,655 | 28,701 | 27,607 | 1,222 | 1,307 | |||
| Operating lease, liability | 713 | ✕ | |||||||
| Business combination, contingent consideration, liability | 7,201 | 4,306 | |||||||
| Other undisclosed liabilities, other than long-term debt | 2,772 | 1,659 | |||||||
| Total noncurrent liabilities: | 86,473 | 91,980 | 95,899 | 108,807 | 80,572 | 49,492 | |||
| Total liabilities: | 124,314 | 121,518 | 131,093 | 137,468 | 96,157 | 66,731 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 10,360 | 17,254 | 15,408 | 13,076 | (8,172) | (8,446) | |||
| Treasury stock, value | (6,533) | (4,594) | (3,143) | (2,264) | (24,504) | (24,108) | |||
| Additional paid in capital | 20,180 | 19,245 | 18,305 | 17,384 | 15,193 | 14,756 | |||
| Accumulated other comprehensive loss | (2,305) | (2,199) | (2,899) | (3,117) | (3,596) | (2,480) | |||
| Retained earnings (accumulated deficit) | (1,000) | 4,784 | 3,127 | 1,055 | 4,717 | 3,368 | |||
| Other undisclosed equity, attributable to parent | 18 | 18 | 18 | 18 | 18 | 18 | |||
| Equity, attributable to noncontrolling interest | 37 | 33 | 28 | 21 | |||||
| Total equity: | 10,397 | 17,287 | 15,436 | 13,097 | (8,172) | (8,446) | |||
| Other undisclosed liabilities and equity | 1,130 | 1,067 | |||||||
| TOTAL LIABILITIES AND EQUITY: | 134,711 | 138,805 | 146,529 | 150,565 | 89,115 | 59,352 | |||
Income Statement (P&L) ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 54,318 | 58,054 | 56,197 | 45,804 | 33,266 | 32,753 | ||
| Cost of revenue | (20,415) | (17,470) | (17,878) | (15,387) | (7,439) | (8,218) | ||
| Cost of product and service sold | (20,415) | (17,414) | (17,446) | (15,387) | (7,439) | (7,718) | ||
| Gross profit: | 33,903 | 40,584 | 38,319 | 30,417 | 25,827 | 24,535 | ||
| Operating expenses | (21,325) | (22,467) | (20,395) | (19,054) | (13,734) | (18,152) | ||
| Other operating income (expense), net | 179 | (56) | (432) | 890 | (500) | |||
| Other expenses | (500) | |||||||
| Other undisclosed operating income | 56 | 432 | 500 | |||||
| Operating income: | 12,757 | 18,117 | 17,924 | 11,363 | 12,983 | 6,383 | ||
| Nonoperating income (expense) | (4,283) | (2,410) | (2,512) | (5,511) | (2,773) | 162 | ||
| Investment income, nonoperating | 540 | 186 | 39 | 174 | 275 | 204 | ||
| Other nonoperating expense | (4,677) | (2,448) | (2,500) | (5,614) | (3,006) | (18) | ||
| Interest and debt expense | (2,224) | (2,230) | (2,423) | (2,454) | (1,784) | (1,348) | ||
| Income from continuing operations before equity method investments, income taxes: | 6,250 | 13,477 | 12,989 | 3,398 | 8,426 | 5,197 | ||
| Other undisclosed loss from continuing operations before income taxes | ||||||||
| Income from continuing operations before income taxes: | 6,250 | 13,477 | 12,989 | 3,398 | 8,426 | 5,197 | ||
| Income tax expense (benefit) | (1,377) | (1,632) | (1,440) | 1,224 | (544) | 490 | ||
| Income from continuing operations: | 4,873 | 11,845 | 11,549 | 4,622 | 7,882 | 5,687 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 11,549 | 4,622 | 7,882 | 5,687 | |
| Net income: | 4,873 | 11,845 | 11,549 | 4,622 | 7,882 | 5,687 | ||
| Net loss attributable to noncontrolling interest | (10) | (9) | (7) | (6) | ||||
| Net income attributable to parent: | 4,863 | 11,836 | 11,542 | 4,616 | 7,882 | 5,687 | ||
| Other undisclosed net loss available to common stockholders, basic | (43) | (54) | (74) | (60) | (40) | (30) | ||
| Net income available to common stockholders, diluted: | 4,820 | 11,782 | 11,468 | 4,556 | 7,842 | 5,657 | ||
Comprehensive Income ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 4,873 | 11,845 | 11,549 | 4,622 | 7,882 | 5,687 | ||
| Other comprehensive income (loss) | (106) | 700 | 218 | 479 | ||||
| Comprehensive income: | 4,767 | 12,545 | 11,767 | 5,101 | 7,882 | 5,687 | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (10) | (9) | (7) | (6) | ||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (1,116) | 247 | ||||||
| Comprehensive income, net of tax, attributable to parent: | 4,757 | 12,536 | 11,760 | 5,095 | 6,766 | 5,934 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.